- 5901. aldehyde oxidase
- [An aldehyde oxidoreductase expressed predominantly in the LIVER; LUNGS; and KIDNEY. It catalyzes the oxidation of a variety of organic aldehydes and N-heterocyclic compounds to CARBOXYLIC ACIDS, and also oxidizes QUINOLINE and PYRIDINE derivatives. The enzyme utilizes molybdenum cofactor and FAD as cofactors. ( MSH )] (UMLS (CSP) C0051124) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 5951. Algic
- (UMLS (HL7) C1699687) =Language =AmericanIndianAlaskaNativeLanguages;
=Algonquian;
Ritwan;
|
- 5902. aldehyde reductase
- [aldose reductase converts glucose to sorbitol, mediating sorbitol toxicity (neuropathy and retinopathy) in diabetes mellitus do not confuse with EC 1.1.1.1, ALCOHOL DEHYDROGENASE. ( CSP )] (UMLS (CSP) C0002003) =Amino Acid, Peptide, or Protein; Enzyme
| - 5952. algicide
- [ ] (UMLS (CSP) C0303927) =Hazardous or Poisonous Substance ;
|
- 5903. aldehyde/ketone oxidoreductase
- [ ] (UMLS (CSP) C0596065) =Amino Acid, Peptide, or Protein; Enzyme =dehydrogenase;
=glyceraldehyde 3 phosphate dehydrogenase;
alpha ketoglutarate dehydrogenase;
pyruvate dehydrogenase;
pyruvate oxidase;
aldehyde dehydrogenase;
| - 5953. ALGONEURODYSTROPHY
- (UMLS (ICD9CM) C0205930) =Disease or Syndrome ;
|
- 5904. aldolase
- [An enzyme of the lyase class that catalyzes the cleavage of fructose 1,6-biphosphate to form dihydroxyacetone phosphate and glyceraldehyde 3-phosphate. The enzyme also acts on (3S,4R)-ketose 1-phosphates. The yeast and bacterial enzymes are zinc proteins. (Enzyme Nomenclature, 1992) E.C. 4.1.2.13. ( MSH )] (UMLS (CSP) C0016762) =Amino Acid, Peptide, or Protein; Enzyme
| - 5954. Algonquian
- (UMLS (HL7) C0574529) =Language =Algic;
=Cheyenne;
Blackfoot;
Menominee;
CreeMontagnais;
SaukFoxKickapoo;
Arapahoan;
EasternAlgonquin;
Ojibwayan;
|
- 5905. Aldomet
- (UMLS (NCI) C0591055) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
| - 5955. algorithm
- [A defined procedure for solving a problem. Applied to a problem-solving procedure implemented in software to be executed by a computer. ( NCI )] (UMLS (CSP) C0002045) =Intellectual Product
|
- 5906. aldosterone hypertension
- [ ] (UMLS (CSP) C0920393) =Pathologic Function ;
| - 5956. algorithm
- [Reaching a decision through the application of an algorithm designed to weigh the different factors involved. ( HL7V3.0 )] (UMLS (HL7) C1553907) =Laboratory Procedure =DecisionObservationMethod;
=bayesian calculation;
|
- 5907. aldosterone inhibitor
- [agent that counteracts or opposes the action of aldosterone. ( CSP )] (UMLS (CSP) C0002007) =Pharmacologic Substance
| - 5957. ALH
- (UMLS (NCI) C1368920) Atypical Breast Lobular Hyperplasia;
Atypical Lobular Breast Hyperplasia;
Atypical Lobular Hyperplasia of Breast;
Atypical Lobular Hyperplasia of the Breast =Pathologic Function |
- 5908. aldosterone receptor
- [Cytoplasmic proteins that specifically bind aldosterone and mediate its cellular effects. The aldosterone-bound receptor acts in the nucleus to regulate the transcription of specific segments of DNA. ( MSH )] (UMLS (CSP) C0051133) =Amino Acid, Peptide, or Protein; Receptor ;
| - 5958. Alias
- [An alias, typically a shorter name than the legal name. This is the default. ( HL7V3.0 )] (UMLS (HL7) C1550728) =Conceptual Entity =OrganizationNameType;
|
- 5909. Aldosterone Receptor
- [Highly expressed as 4 alternative isoforms in kidney and sweat glands by human NR3C2 Gene (NR3 Family), ubiquitous phosphorylated Mineralocorticoid Receptor contains an N-terminal modulating domain, a DNA-binding domain, and a C-terminal steroid (mineralocorticoid/glucocorticoid)-binding domain. Absent ligand, NR3C2 resides in a heteromultimeric cytoplasmic complex with HSP90, HSP70, and FKBP4 or with HSD11B2 in the ER membrane. Ligand-activated NR3C2 translocates to the nucleus, binds to DNA mineralocorticoid response elements as a homodimer or heterodimer with NR3C1, and transactivates target gene expression, which increases ion and water transport; raises extracellular fluid volume and blood pressure; and lowers potassium levels. NR3C2 appears to bind NCOA1, NCOA2, TIF1, and NRIP1. NR3C2 defects cause PHA1 and early onset hypertension. (NCI) ( NCI )] (UMLS (NCI) C0066563) =Amino Acid, Peptide, or Protein; Receptor ;
| - 5959. Alias Name
- (UMLS (HL7) C1549651) =Idea or Concept =Name type;
|
- 5910. aldosterone stimulant
- [ ] (UMLS (CSP) C0599480) =Steroid; Pharmacologic Substance; Hormone
| - 5960. Alias name
- (UMLS (HL7) C1549760) =Idea or Concept =Organizational name type;
|
- 5911. aldosteronism
- [abnormality of electrolyte function caused by excessive secretion of aldosterone by the adrenal cortex. ( CSP )] (UMLS (CSP) C0020428) =Disease or Syndrome =adrenal disorder;
Adrenal Gland Hyperfunction =Bartter's Disease;
CONN'S SYNDROME;
Bartter's Disease;
| - 5961. Alimentary Canal
- [The tube that extends from the mouth to the anus in which the movement of muscles and release of hormones and enzymes digest food. The gastrointestinal tract starts with the mouth and proceeds to the esophagus, stomach, duodenum, small intestine, large intestine (colon), rectum and, finally, the anus. It does not include the accessory glandular organs. ( NCI )] (UMLS (NCI) C0017189) =Body System ;
|
- 5912. Aldrich syndrome
- [rare x-linked immunodeficiency syndrome of young boys characterized by eczema, thrombocytopenic purpura and recurrent pyogenic infection; IGM levels are low and IGA and IGE levels are elevated; lymphoreticular malignancies are common. ( CSP )] (UMLS (CSP) C0043194) =Disease or Syndrome ;
=HEMORRHAGIC COND NOS;
Genetic Condition;
hypoimmunity;
Congenital anomalies of the integument;
syndrome;
thrombocytopenia;
inborn immunodeficiency;
Purpura, Thrombocytopenic | - 5962. Alimta
- (UMLS (NCI) C1101816) =Organic Chemical; Pharmacologic Substance ;
|
- 5913. aldrin
- [A highly poisonous substance that was formerly used as an insecticide. The manufacture and use has been discontinued in the U.S. (From Merck Index, 11th ed) ( MSH )] (UMLS (CSP) C0002011) =Organic Chemical; Hazardous or Poisonous Substance ;
| - 5963. Alinia
- (UMLS (NCI) C1170029) =Organic Chemical; Pharmacologic Substance ;
|
- 5914. Alemtuzumab
- [A monoclonal antibody used to treat leukemia. Monoclonal antibodies are made in the laboratory. They can find cancer cells and bind to them. Also called Campath-1H. ( NCI )] (UMLS (NCI) C0383429) =Organic Chemical; Pharmacologic Substance; Immunologic Factor =[AN000] ANTINEOPLASTICS;
Unclassified Ingredients =ALEMTUZUMAB 10 MG/ML | - 5964. aliquot
- [Pertaining to a portion of the whole; any one of two or more samples of something, of the same volume or weight. ( NCI )] (UMLS (HL7) C1510844) =Quantitative Concept ;
=Specimen Child Role;
specimen |
- 5915. Alemtuzumab/Cyclophosphamide/Doxorubicin/Etoposide/Prednisone/Vincristine
- (UMLS (NCI) C1328084) =Therapeutic or Preventive Procedure ;
| - 5965. ALISKIREN
- (UMLS (NCI) C1120110) =Organic Chemical; Pharmacologic Substance ;
|
- 5916. Alemtuzumab/Cyclophosphamide/Fludarabine
- (UMLS (NCI) C1134603) =Therapeutic or Preventive Procedure
| - 5966. Alive
- [The organic phenomenon that distinguishes living organisms from nonliving ones; showing characteristics of life. ( NCI )] (UMLS (NCI) C0376558) =Idea or Concept
|
- 5917. Alemtuzumab/Fludarabine
- (UMLS (NCI) C1327792) =Therapeutic or Preventive Procedure ;
| - 5967. Alizapride
- [A substituted benzamide that acts as a dopamine receptor antagonist with antiemetic properties. ( NCI )] (UMLS (NCI) C0051162) =Organic Chemical; Pharmacologic Substance ;
|
- 5918. Alemtuzumab/Fludarabine/Melphalan
- (UMLS (NCI) C1134523) =Therapeutic or Preventive Procedure
| - 5968. ALK
- [The 2;5 chromosomal translocation is frequently associated with anaplastic large cell lymphomas (ALCLs). The translocation creates a fusion gene consisting of the ALK (anaplastic lymphoma kinase) gene and the nucleophosmin (NPM) gene: the 3' half of ALK, derived from chromosome 2, is fused to the 5' portion of NPM from chromosome 5. A recent study shows that the product of the NPM-ALK fusion gene is oncogenic. The deduced amino acid sequences reveal that ALK is a novel receptor protein-tyrosine kinase having a putative transmembrane domain and an extracellular domain. These sequences are absent in the product of the transforming NPM-ALK gene. ALK shows the greatest sequence similarity to LTK (leukocyte tyrosine kinase). ALK plays an important role in the development of the brain and exerts its effects on specific neurons in the nervous system. (LocusLink) ( NCI )] (UMLS (NCI) C0252409) =Amino Acid, Peptide, or Protein; Enzyme
|
- 5919. ALENDRONATE SODIUM
- [A drug that affects bone metabolism. It is used in treating osteoporosis and Paget's disease, and is being studied in the treatment of hypercalcemia (abnormally high levels of calcium in the blood) and in treating and reducing the risk of bone pain caused by cancer. Alendronate sodium belongs to the family of drugs called bisphosphonates. ( NCI )] (UMLS (NCI) C0700482) =Organophosphorus Compound; Pharmacologic Substance
| - 5969. ALK
- [This gene is involved in brain development and neuronal specificity. ( NCI )] (UMLS (NCI) C1332080) ALK Gene;
Anaplastic Lymphoma Kinase (Ki-1) Gene;
=Gene or Genome |
- 5920. Alendronate Sodium/Ketoconazole
- (UMLS (NCI) C0796551) KCZ/MK-217 =Therapeutic or Preventive Procedure
| - 5970. ALK-DLBCL
- (UMLS (NCI) C1333294) Diffuse Large B-Cell Lymphoma with Expression of Full-Length ALK;
Diffuse Large B-Cell Lymphoma with Expression of Full-Length Anaplastic Lymphoma Kinase;
=Neoplastic Process ;
|
- 5921. Alendronic Acid
- [A second generation bisphosphonate and synthetic analog of pyrophosphate with anti-resorption activity. Alendronate sodium binds to and inhibits the activity of geranyltranstransferase (farnesyl pyrophosphate synthetase), an enzyme involved in terpenoid biosynthesis. Inhibition of this enzyme prevents the biosynthesis of isoprenoid lipids (FPP and GGPP) that are donor substrates of farnesylation and geranylgeranylation during the post-translational modification of small GTPase signalling proteins, which is important in the process of osteoclast turnover. As a result, bone resorption and turnover are reduced. ( NCI )] (UMLS (NCI) C0771311) =Organophosphorus Compound; Pharmacologic Substance
| - 5971. ALK-Negative Anaplastic Large Cell Lymphoma
- (UMLS (NCI) C1332078) =Neoplastic Process
|
- 5922. Alendros
- (UMLS (NCI) C1510842) =Organophosphorus Compound; Pharmacologic Substance
| - 5972. Alka Seltzer
- (UMLS (NCI) C0051166) =Pharmacologic Substance
|
- 5923. alentemol
- [ ] (UMLS (CSP) C0597883) =Pharmacologic Substance ;
| - 5973. ALKAL BURN CORNEA/CONJUN
- [ ] (UMLS (ICD9CM) C0161030) =Injury or Poisoning
|
- 5924. Alert Device Code
- (UMLS (HL7) C1547818) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Bracelet;
Necklace;
Wallet Card;
| - 5974. alkali metal
- [metals that constitute group 1(formerly group Ia) of the periodic table; they are the most strongly electropositive of the metals; note that hydrogen is not considered an alkali metal even though it falls under the group 1 heading in the periodic table. ( CSP )] (UMLS (CSP) C0025554) =Element, Ion, or Isotope =Element;
metal =cesium;
Li element;
[TN403] POTASSIUM;
Rb element;
[TN404] SODIUM;
[TN403] POTASSIUM;
Rb element;
[TN404] SODIUM |
- 5925. Alert level
- (UMLS (HL7) C1547761) =Qualitative Concept =HL7 Vocabulary Version 2.5;
=Normal;
Warning;
Serious;
Critical;
| - 5975. alkaline earth metal
- [bivalent metals that constitute the group 2 (formerly group IIa) of the periodic table; they are Be, Mg, Ca, Sr, Ba and Ra. ( CSP )] (UMLS (CSP) C0025555) =Element, Ion, or Isotope =Element;
metal =Ba;
Be;
[TN402] CALCIUM;
[TN406] MAGNESIUM;
Sr;
[TN402] CALCIUM;
Sr;
|
- 5926. alertness
- [ ] (UMLS (CSP) C1443086) =Mental Process ;
| - 5976. alkaline phosphatase
- [An enzyme that catalyses the cleavage of inorganic phosphate non-specifically from a wide variety of phosphate esters and having a high (greater than 8) pH optimum. ( NCI )] (UMLS (CSP) C0002059) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 5927. Alethine
- [A substance that is being studied as a treatment for cancer. It belongs to a family of chemicals called disulfides. ( NCI )] (UMLS (NCI) C0290021) =Organic Chemical; Pharmacologic Substance ;
| - 5977. Alkaline Phosphatase
- [A quantitative measurement of alkaline phosphatase present in a sample. ( NCI )] (UMLS (NCI) C0201850) =Laboratory Procedure
|
- 5928. Aleukemic Leukemia
- [A leukemia characterised by the absence of leukemic cells in the peripheral blood. — 2003 ( NCI )] (UMLS (NCI) C0877858) =Neoplastic Process
| - 5978. alkalinity
- [ ] (UMLS (CSP) C0597742) =Quantitative Concept ;
|
- 5929. Aleukemic Leukemia Cutis
- (UMLS (NCI) C0887846) =Neoplastic Process
| - 5979. alkalinization
- [(AL-ka-LIN-ih-ZAY-shun) The process by which a substance becomes an alkali. An alkali is the opposite of an acid. ( NCI )] (UMLS (NCI) C1510847) =Molecular Function ;
|
- 5930. Aleukemic Lymphatic Leukemia
- (UMLS (NCI) C0334667) =Neoplastic Process
| - 5980. Alkalinizing Agent Preparation
- [Used topically or systemically for management of metabolic acidosis, improved muscle contraction, and hyper-acidic conditions, Alkalinizing Agent Preparations contain one or more substances with basic properties, such as sodium bicarbonate, sodium citrate, and phosphate salts (potassium phosphate, sodium acid phosphate, and tribasic sodium phosphate). Usually the alkalinizing agent(s) acts as a proton acceptor, neutralizing the acidity of a biologic environment (skin, gastric content, urine, etc.) and raising the pH. (NCI04) ( NCI )] (UMLS (NCI) C1510848) =Pharmacologic Substance ;
|
- 5931. Aleukemic Lymphoblastic Leukemia
- (UMLS (NCI) C1332230) Aleukemic Precursor Lymphoblastic Leukemia;
=Neoplastic Process ;
| - 5981. Alkalization
- (UMLS (HL7) C1550103) =Therapeutic or Preventive Procedure ;
=Therapeutic Interventions;
◊ [The act rendering alkaline by impregnating with an alkali; a conferring of alkaline qualities. ( HL7V3.0 )] (UMLS (HL7) C1551382) Laboratory Procedure ActSpecimenTreatmentCode; |
- 5932. Aleukemic Lymphoblastic Leukemia Cutis
- (UMLS (NCI) C1332231) Aleukemic Precursor Lymphoblastic Leukemia Cutis;
=Neoplastic Process ;
| - 5982. alkaloid
- [organic nitrogenous bases; many alkaloids of medical importance occur in the animal and vegetable kingdoms. ( CSP )] (UMLS (CSP) C0002062) =Organic Chemical
|
- 5933. Aleukemic Monocytic Leukemia Cutis
- (UMLS (NCI) C1332232) =Neoplastic Process ;
| - 5983. Alkaloid Biosynthesis I
- (UMLS (NCI) C1510850) Alkaloid Biosynthesis I Pathway;
=Molecular Function ;
|
- 5934. Aleurain
- [This protein is a lysosomal cysteine proteinase important in the overall degradation of lysosomal proteins. It is composed of a dimer of disulfide-linked heavy and light chains, both produced from a single protein precursor. The protein, which belongs to the peptidase C1 protein family, can act both as an aminopeptidase and as an endopeptidase. Increased expression of this gene has been correlated with malignant progression of prostate tumors. (from LocusLink) ( NCI )] (UMLS (NCI) C0054869) =Amino Acid, Peptide, or Protein; Enzyme
| - 5984. Alkaloid Biosynthesis II
- (UMLS (NCI) C1510849) Alkaloid Biosynthesis II Pathway;
=Molecular Function ;
|
- 5935. Aleut
- (UMLS (HL7) C0574292) =Language =Aleut;
SirenikskiYupik;
EskimoAleut;
=Aleut | - 5985. alkalosis
- [pathological condition that removes acid or adds base to the body fluids. ( CSP )] (UMLS (CSP) C0002063) =Disease or Syndrome
|
- 5936. Aleut
- (UMLS (NCI) C0085766) =Population Group ;
=Alaska Indian;
=Alutiiq Aleut;
Chugach Aleut;
Eyak;
Koniag Aleut;
Sugpiaq;
Suqpigaq;
Unangan Aleut;
Bristol Bay Aleut;
| - 5986. alkane
- [generic name for the group of aliphatic hydrocarbons Cn-H2n+2; they are denoted by the suffix -ane. ( CSP )] (UMLS (CSP) C0002065) =Organic Chemical
|
- 5937. Aleutian mink disease
- [A slow progressive disease of mink caused by the ALEUTIAN MINK DISEASE VIRUS. It is characterized by poor reproduction, weight loss, autoimmunity, hypergammaglobulinemia, increased susceptibility to bacterial infections, and death from renal failure. The disease occurs in all color types, but mink which are homozygous recessive for the Aleutian gene for light coat color are particularly susceptible. ( MSH )] (UMLS (CSP) C0002016) =Disease or Syndrome
| - 5987. Alkanesulfonates
- [any compound of the type R-SO3-. ( CSP )] (UMLS (NCI) C0002072) =Organic Chemical
|
- 5938. Aleutian mink disease parvovirus
- [A species of PARVOVIRUS that causes a disease in mink, mainly those homozygous for the recessive Aleutian gene which determines a desirable coat color. ( MSH )] (UMLS (CSP) C0002017) =Virus
| - 5988. Alkansea
- (UMLS (HL7) C1551966) Arkansas;
=Language =Dhegiha;
|
- 5939. Alexander technique
- [ ] (UMLS (CSP) C0597812) =Therapeutic or Preventive Procedure
| - 5989. alkene
- [unsaturated hydrocarbons of the type Cn-H2n, indicated by the suffix -ene. ( CSP )] (UMLS (CSP) C0002068) =Organic Chemical
|
- 5940. Alexander's disease
- [A rare inherited disorder of myelin formation. Alexander disease is a progressive leukoencephalopathy whose hallmark is the widespread accumulation of cytoplasmic inclusions called Rosenthal fibers. The fibers contain GLIAL FIBRILLARY ACIDIC PROTEIN in association with ALPHA-CRYSTALLIN B CHAIN. Rosenthal fibers are found predominantly in ASTROCYTES located in the subependymal, subpial, and periventricular areas of the BRAIN. ( MSH )] (UMLS (CSP) C0270726) =Disease or Syndrome
| - 5990. Alkeran
- (UMLS (NCI) C0591063) =Amino Acid, Peptide, or Protein; Pharmacologic Substance
|
- 5941. ALEXIA
- (UMLS (ICD9CM) C0002018) =Disease or Syndrome
| - 5991. ALKoma
- (UMLS (NCI) C1332079) ALK-Positive Anaplastic Large Cell Lymphoma =Neoplastic Process
|
- 5942. ALEXIA AND DYSLEXIA
- (UMLS (ICD9CM) C0002019) =Mental or Behavioral Dysfunction
| - 5992. alkyl group
- [any of a series of univalent groups of the general formula CnH2n+1 derived from aliphatic hydrocarbons. ( CSP )] (UMLS (CSP) C0596066) =Organic Chemical ;
=chemical group;
=methyl group;
|
- 5943. ALF
- [This gene plays a role in germ cell-specific transcription. ( NCI )] (UMLS (NCI) C1332077) ALF Gene;
TFIIA-Alpha/Beta-Like Factor Gene;
=Gene or Genome | - 5993. alkyl nitrile
- [ ] (UMLS (CSP) C0596067) =Organic Chemical; Hazardous or Poisonous Substance =cyanide;
=CNBr;
beta aminopropionitrile |
- 5944. alfalfa
- [plant species of the family Fabaceae widely cultivated for animal feed. ( CSP )] (UMLS (CSP) C0002022) =Plant
| - 5994. alkyl substitution
- [ ] (UMLS (CSP) C0598140) =Molecular Function ;
|
- 5945. alfalfa mosaic virus
- [The type species of the genus ALFAMOVIRUS that is non-persistently transmitted by aphids. ( MSH )] (UMLS (CSP) C0206265) =Virus ;
| - 5995. Alkyl-Guanine Transferase Inhibitor
- [Substances that inhibit 06-Alkylguanine-DNA Alkyltransferase, a DNA repair enzyme, and interferes with the enzymes ability to remove alkyl adducts from DNA. ( NCI )] (UMLS (NCI) C1510851) O6-Alkylguanine-DNA Alkyltransferase Inhibitor;
O6-Alkylguanine-DNA Alkyltransferase Inhibitors =Pharmacologic Substance ;
|
- 5946. Alfenta
- (UMLS (NCI) C0002025) =Organic Chemical; Pharmacologic Substance ;
| - 5996. Alkylating Agent Related Acute Myeloid Leukemia
- (UMLS (NCI) C1332233) Alkylating Agent-Related Acute Myeloid Leukemia;
Alkylating Agent-Related AML =Neoplastic Process ;
|
- 5947. alfentanil
- [An ultra short-acting, synthetic, opioid agonist with analgesic and local anesthesia enhancing activity. Alfentanil primarily binds to and stimulates the opiate receptors in the central nervous system (CNS), thereby mimicking the actions of endogenous opioids. Stimulation of the mu-subtype opioid receptor stimulates the exchange of GTP for GDP on the G-protein complex and subsequently inhibits adenylate cyclase. This results in a decrease in intracellular cAMP and leads to a reduction in the release of various neurotransmitters. The analgesic effect of alfentanil is likely due to the actions of its metabolite morphine, which induces opening of G-protein-coupled inwardly rectifying potassium (GIRK) channels and blocks the opening of N-type voltage-gated calcium channels, thereby resulting in hyperpolarization and reduced neuronal excitability. ( NCI )] (UMLS (CSP) C0002026) =Organic Chemical; Pharmacologic Substance ;
| - 5997. Alkylating Agent Related Acute Myeloid Leukemia and Myelodysplastic Syndrome
- (UMLS (NCI) C1332234) Alkylating Agent-Related Acute Myeloid Leukemia and Myelodysplastic Syndrome;
Alkylating Agent-Related AML and MDS =Neoplastic Process ;
|
- 5948. ALG
- [Immunoglobulins raised xenogeneically against lymphocyte populations. It is used both as a test for histocompatibility and in conjunction with other immunosuppressive agents to suppress rejection of grafts or organ transplants. ( NCI )] (UMLS (NCI) C0003372) =Pharmacologic Substance; Immunologic Factor ;
| - 5998. Alkylating Agent Related Myelodysplastic Syndrome
- (UMLS (NCI) C1332235) Alkylating Agent-Related Myelodysplastic Syndrome;
=Neoplastic Process ;
|
- 5949. Algaaciq Native Village (St. Mary's)
- (UMLS (HL7) C1550802) =Population Group =NativeEntityAlaska;
| - 5999. alkylation
- [substitution of an alkyl group for an active hydrogen atom in an organic compound. ( CSP )] (UMLS (CSP) C0002074) =Natural Phenomenon or Process
|
- 5950. algae
- [major group of lower freshwater, marine, terrestrial or subterranean photosynthetic plants of extremely varied morphology and physiology, and that is commonly considered to be a heterogeneous assemblage. ( CSP )] (UMLS (CSP) C0002028) =Alga
| - 6000. alkylphosphate
- [metabolites of organophosphate pesticides. ( CSP )] (UMLS (CSP) C0596068) =Organophosphorus Compound ;
=phosphate;
=DFP;
EHDP |
home 
Armenian-English 
top